Dr. Sridhar Ramaswamy from the Massachusetts General Hospital Cancer Center Discusses Tumor Heterogeneity
Sridhar Ramaswamy, MD
Advertisement
Articles by Sridhar Ramaswamy, MD
Dr. Sridhar Ramaswamy, from Massachusetts General Hospital Cancer Center, on Dormant Tumor Cells and Resistance
Dr. Sridhar Ramaswamy, from Massachusetts General Hospital Cancer Center, on Targeting Dormant Cancer Cells
Advertisement
Latest Updated Articles
Dr. Ramaswamy on Targeting Dormant Cancer CellsPublished: February 1st 2012 | Updated:
Dr. Ramaswamy on Dormant Tumor Cells and ResistancePublished: February 13th 2012 | Updated:
Dr. Ramaswamy Discusses Tumor HeterogeneityPublished: March 7th 2012 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer
2
NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer
3
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
4
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
5